Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prurigo Nodularis”

52 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 52 results

Not applicableLooking for participantsNCT06988618
What this trial is testing

Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults

Who this might be right for
Prurigo Nodularis
Galderma R&D 600
Large-scale testing (Phase 3)Study completedNCT04501679
What this trial is testing

Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

Who this might be right for
Prurigo Nodularis
Galderma R&D 274
Large-scale testing (Phase 3)Study completedNCT02174432
What this trial is testing

Open Label Extension Study of Nalbuphine HCl ER in Patients With Prurigo Nodularis

Who this might be right for
Prurigo NodularisNodularis PrurigoPrurigo
Trevi Therapeutics 36
Not applicableUnknownNCT00532519
What this trial is testing

Effectiveness of the Selective Serotonin Reuptake Inhibitor,Citalopram (Cipralex), in Prurigo Nodularis

Who this might be right for
Prurigo Nodularis
Hadassah Medical Organization
Large-scale testing (Phase 3)Study completedNCT02174419
What this trial is testing

Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis

Who this might be right for
Prurigo NodularisNodularis PrurigoPrurigo+1 more
Trevi Therapeutics 62
Not applicableLooking for participantsNCT07276425
What this trial is testing

Early and Long-Term Efficacy and Immune Changes With Dupilumab in Prurigo Nodularis

Who this might be right for
Prurigo Nodularis (PN)
UMC Utrecht 40
Testing effectiveness (Phase 2)Study completedNCT02196324
What this trial is testing

Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN)

Who this might be right for
Prurigo Nodularis
Vyne Therapeutics Inc. 128
Large-scale testing (Phase 3)Study completedNCT03677401
What this trial is testing

Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis

Who this might be right for
PruritusPrurigo Nodularis
Vyne Therapeutics Inc. 295
Testing effectiveness (Phase 2)Active Not RecruitingNCT06366750
What this trial is testing

Barzolvolimab in Patients With Prurigo Nodularis

Who this might be right for
Prurigo Nodularis
Celldex Therapeutics 140
Not applicableUnknownNCT01870050
What this trial is testing

Dapsone Prurigo Study

Who this might be right for
Lichen Simples Chronicus and Prurigo
Cook County Health 20
Early research (Phase 1)Study completedNCT06213831
What this trial is testing

Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream

Who this might be right for
Prurigo Nodularis
Incyte Corporation 23
Not applicableLooking for participantsNCT05928169
What this trial is testing

Determinants of Chronic Inflammatory Skin Disease Trajectories

Who this might be right for
Atopic DermatitisPsoriasisLichen Planus+5 more
University Hospital Schleswig-Holstein 1,000
Not applicableUnknownNCT04681300
What this trial is testing

Transcriptomic Landscape of T Lymphocytes of Atopic Dermatitis, Atopic Prurigo Nodularis (of Besnier) and Non-atopic Prurigo Nodularis (of Hyde) Using Single Cell RNA-sequencing

Who this might be right for
Prurigo NodularisAtopic Dermatitis
Assistance Publique - Hôpitaux de Paris 20
Large-scale testing (Phase 3)Study completedNCT03546816
What this trial is testing

Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis

Who this might be right for
PruritusPrurigo Nodularis
Vyne Therapeutics Inc. 285
Not applicableStudy completedNCT05451316
What this trial is testing

Assess Change in Disease Activity in Adolescents and Adults With Moderate to Severe Prurigo-type Atopic Dermatitis in Japan Who Are Treated With Oral Upadacitinib

Who this might be right for
Atopic Dermatitis
AbbVie 1
Large-scale testing (Phase 3)Study completedNCT06424470
What this trial is testing

Study on the Treatment of Prurigo Nodularis With Stapokibart Injection

Who this might be right for
Prurigo Nodularis
Keymed Biosciences Co.Ltd 200
Large-scale testing (Phase 3)Study completedNCT05764161
What this trial is testing

Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)

Who this might be right for
Prurigo Nodularis
Incyte Corporation 190
Not applicableActive Not RecruitingNCT06087627
What this trial is testing

A Non-interventional Study to Describe the Dupilumab Long-term Treatment, Safety and Patient Reported Outcomes in Chronic Nodular Prurigo (Prurigo Nodularis) in Clinical Routine

Who this might be right for
Prurigo Nodularis
Sanofi 110
Large-scale testing (Phase 3)Active Not RecruitingNCT04204616
What this trial is testing

A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

Who this might be right for
Prurigo Nodularis
Galderma R&D 500
Post-approval studies (Phase 4)Ended earlyNCT06773403
What this trial is testing

Upadacitinib for Prurigo Nodularis

Who this might be right for
Prurigo Nodularis
Psoriasis Treatment Center of Central New Jersey 5
Next Page